Find the Perfect Plan for Your Investment Journey
B
Latest price
52 Week Range
CA$0.04 - CA$0.09
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$11.74M |
EV | CA$11.65M |
Shares Outstanding | 293.43M |
Beta | -0.14 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E undefinedE | - |
P/Revenue undefinedE | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin undefinedE | - |
Net Profit Margin undefinedE | - |
ROE undefinedE | - |
ROCE | - |
DPS undefinedE | - |
Payout Ratio undefinedE | - |
Div. Yield undefinedE | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
BioVaxys Technology Corp.
BIOV
Sector
Healthcare
Industry
Biotechnology
CEO
Passin, James
Employees
Website
biovaxys.comIPO Date
2018-11-27
Headquarters
146 Thirtieth Street, Suite 100, Etobicoke, Ontario, M8W 3D4, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved